Deregulated WNT signaling in childhood T-cell acute lymphoblastic leukemia

被引:0
|
作者
O H Ng
Y Erbilgin
S Firtina
T Celkan
Z Karakas
G Aydogan
E Turkkan
Y Yildirmak
C Timur
E Zengin
J J M van Dongen
F J T Staal
U Ozbek
M Sayitoglu
机构
[1] Institute for Experimental Medicine,Department of Genetics
[2] Istanbul University,Department of Pediatrics Hematology
[3] Cerrahpasa Medical Faculty,Department of Pediatric Hematology
[4] Istanbul University,Pediatric Hematology Division
[5] Istanbul Medical Faculty,Pediatric Hematology Division
[6] Istanbul University,Pediatric Hematology Division
[7] Istanbul Kanuni Sultan Suleyman Education and Research Hospital,Pediatric Hematology Division
[8] Istanbul Okmeydani Education and Research Hospital,Pediatric Hematology Division
[9] Ministry of Health Sisli Etfal Education and Research Hospital,Department of Immunology
[10] Medeniyet University Medical Faculty,Department of Immunohematology and Blood Transfusion
[11] Kocaeli University Medical Faculty,undefined
[12] Erasmus Medical Center,undefined
[13] Leiden University Medical Center,undefined
来源
Blood Cancer Journal | 2014年 / 4卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
WNT signaling has been implicated in the regulation of hematopoietic stem cells and plays an important role during T-cell development in thymus. Here we investigated WNT pathway activation in childhood T-cell acute lymphoblastic leukemia (T-ALL) patients. To evaluate the potential role of WNT signaling in T-cell leukomogenesis, we performed expression analysis of key components of WNT pathway. More than 85% of the childhood T-ALL patients showed upregulated β-catenin expression at the protein level compared with normal human thymocytes. The impact of this upregulation was reflected in high expression of known target genes (AXIN2, c-MYC, TCF1 and LEF). Especially AXIN2, the universal target gene of WNT pathway, was upregulated at both mRNA and protein levels in ∼40% of the patients. When β-CATENIN gene was silenced by small interfering RNA, the cancer cells showed higher rates of apoptosis. These results demonstrate that abnormal WNT signaling activation occurs in a significant fraction of human T-ALL cases independent of known T-ALL risk factors. We conclude that deregulated WNT signaling is a novel oncogenic event in childhood T-ALL.
引用
收藏
页码:e192 / e192
相关论文
共 50 条
  • [41] T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma: One disease or two?
    Raetz, EA
    Perkins, SL
    Bhojwani, D
    Carroll, WL
    Min, DJ
    BLOOD, 2003, 102 (11) : 578A - 578A
  • [42] Oncogenetic landscape of T-cell lymphoblastic lymphomas compared to T-cell acute lymphoblastic leukemia
    Bontoux, Christophe
    Simonin, Mathieu
    Garnier, Nathalie
    Lhermitte, Ludovic
    Touzart, Aurore
    Andrieu, Guillaume
    Bruneau, Julie
    Lengline, Etienne
    Plesa, Adriana
    Boissel, Nicolas
    Baruchel, Andre
    Bertrand, Yves
    Molina, Thierry Jo
    Macintyre, Elizabeth
    Asnafi, Vahid
    MODERN PATHOLOGY, 2022, 35 (09) : 1227 - 1235
  • [43] Casitas B-cell lymphoma mutation in childhood T-cell acute lymphoblastic leukemia
    Saito, Yuka
    Aoki, Yoko
    Muramatsu, Hideki
    Makishima, Hideki
    Maciejewski, Jaroslaw P.
    Imaizumi, Masue
    Rikiishi, Takeshi
    Sasahara, Yoji
    Kure, Shigeo
    Niihori, Tetsuya
    Tsuchiya, Shigeru
    Kojima, Seiji
    Matsubara, Yoichi
    LEUKEMIA RESEARCH, 2012, 36 (08) : 1009 - 1015
  • [44] A Non-Canonical Lymphoblast in Refractory Childhood T-Cell Acute Lymphoblastic Leukemia
    Lim, Bram S. J.
    Whitfield, Holly J.
    Trinh, Mi K.
    Bloye, Gianna
    Thomas, Rebecca
    Anderson, Nathaniel D.
    Wenger, Anna
    Hodder, Angus
    Treger, Taryn D.
    Lee-Six, Henry
    Coorens, Tim H. H.
    Parks, Conor
    Ogbonnah, Toochi
    Polonen, Petri
    Mullighan, Charles G.
    Teachey, David T.
    Hagleitner, Melanie M.
    Kester, Lennart A.
    van Leeuwen, Frank N.
    Beattie, Gordon
    Mansour, Marc R.
    Williams, Owen
    Bartram, Jack
    Adams, Stuart
    Jardine, Laura
    Behjati, Sam
    O'Connor, David
    BLOOD, 2024, 144 : 2830 - 2831
  • [45] MORPHOLOGICAL, CYTOCHEMICAL AND IMMUNOLOGICAL PROFILE IN T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA OF CHILDHOOD
    CANTURAJNOLDI, A
    CATTORETTI, G
    SCHIRO, R
    FERRARI, M
    GUERCILENA, S
    BELFORTI, S
    MASERA, G
    HAEMATOLOGICA, 1986, 71 (06) : 467 - 472
  • [46] Mediastinal mass in childhood T-Cell acute lymphoblastic leukemia: Significance and therapy response
    Attarbaschi, A
    Mann, G
    Dworzak, M
    Wiesbauer, P
    Schrappe, M
    Gadner, H
    MEDICAL AND PEDIATRIC ONCOLOGY, 2002, 39 (06): : 558 - 565
  • [47] Mutational analysis of the ATM gene in childhood T-cell acute lymphoblastic leukemia.
    Takeuchi, S
    Koike, M
    Park, S
    Seriu, T
    Bartram, CR
    Miyoshi, I
    Koeffler, HP
    BLOOD, 1997, 90 (10) : 2183 - 2183
  • [48] Genetic hallmarks and clinical implications of chromothripsis in childhood T-cell acute lymphoblastic leukemia
    Pastorczak, Agata
    Urbanska, Zuzanna
    Styka, Borys
    Miarka-Walczyk, Karolina
    Sedek, Lukasz
    Wypyszczak, Kamila
    Wakulinska, Anna
    Nowicka, Zuzanna
    Szczepanski, Tomasz
    Stanczak, Marcin
    Fendler, Wojciech
    Kowalczyk, Jerzy
    Mlynarski, Wojciech
    Lejman, Monika
    LEUKEMIA, 2024, 38 (11) : 2344 - 2354
  • [49] Investigating chemoresistance to improve sensitivity of childhood T-cell acute lymphoblastic leukemia to parthenolide
    Ede, Benjamin C.
    Asmaro, Rafal R.
    Moppett, John P.
    Diamanti, Paraskevi
    Blair, Allison
    HAEMATOLOGICA, 2018, 103 (09) : 1493 - 1501
  • [50] PTEN and AKT1 Variations in Childhood T-Cell Acute Lymphoblastic Leukemia
    Kucukcankurt, Fulya
    Erbilgin, Yucel
    Firtina, Sinem
    Ng, Ozden Hatirnaz
    Karakas, Zeynep
    Celkan, Tiraje
    Unuvar, Aysegul
    Ozbek, Ugur
    Sayitoglu, Muge
    TURKISH JOURNAL OF HEMATOLOGY, 2020, 37 (02) : 98 - 103